REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/26/2025
Back to search
Official data from USPTO
LUSEFY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/27/2025
Trademark type
Word
Nice classes
5
Filing date
07/23/2019
Registration date
05/26/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2020
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
CROSS, TRACY
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Taisho Pharmaceutical Co., Ltd.
Representatives
Holly M. Ford Lewis OLIFF PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human usefor the treatment of diabetes
Publications
History of USPTO decisions and trademark events.
30 publications found
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/08/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/26/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/05/2022
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
12/12/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/23/2020
FIMP
FINAL DISPOSITION PROCESSED
09/23/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/26/2020
GPNX
NOTIFICATION PROCESSED BY IB
08/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2020
PUBO
PUBLISHED FOR OPPOSITION
03/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/19/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2020
RFNT
REFUSAL PROCESSED BY IB
11/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/11/2019
RFRR
REFUSAL PROCESSED BY MPU
10/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/29/2019
CNRT
NON-FINAL ACTION WRITTEN
09/28/2019
DOCK
ASSIGNED TO EXAMINER
09/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/30/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
08/22/2019
Continuous trademark protection
Get notified about every new filing that threatens LUSEFY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.